Prevalence and long-term monitoring of humoral immunity against adeno-associated virus in Duchenne Muscular Dystrophy patients

Autor: Leborgne, Christian, Latournerie, Virginie, Boutin, Sylvie, Desgue, Diana, Quéré, Aliénor, Pignot, Elodie, Collaud, Fanny, Charles, Séverine, Simon Sola, Marcelo, Masat, Elisa, Jouen, Fabienne, Boyer, Olivier, Masurier, Carole, Mingozzi, Federico, Veron, Philippe

Publikováno v: In Cellular Immunology August 2019 342

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Long-term exposure to Myozyme results in a decrease of anti-drug antibodies in late-onset Pompe disease patients

Autor: Masat, Elisa, Laforêt, Pascal, De Antonio, Marie, Corre, Guillaume, Perniconi, Barbara, Taouagh, Nadjib, Mariampillai, Kuberaka, Amelin, Damien, Mauhin, Wladimir, Hogrel, Jean-Yves, Caillaud, Catherine, Ronzitti, Giuseppe, Puzzo, Francesco, Kuranda, Klaudia, Colella, Pasqualina, Mallone, Roberto, Benveniste, Olivier, Mingozzi, Federico, Bassez, G., Bedat-Millet, A. L., Behin, A., Eymard, B., Leonard-Louis, S., Stojkovic, T., Canal, A., Decostre, V., Bouhour, F., Boyer, F., Castaing, Y., Chapon, F., Cintas, P., Durieu, I., Echaniz-Laguna, A., Feasson, L., Furby, A., Hamroun, D., Ferrer, X., Solé, G., Froissart, R., Piraud, M., Germain, D., Benistan, K., Guffon-Fouilhoux, N., Journel, H., Labauge, P., Lacour, A., Levy, A., Magot, A., Péréon, Y., Minot-Myhié, M. -C., Nadaj-Pakleza, A., Nathier, C., Orlikowski, D., Pellegrini, N., Petiot, P., Praline, J., Lofaso, F., Prigent, H., Dutry, A., Renard, D., Sacconi, S., Desnuelle, C., Salort-Campana, E., Pouget, J., Tiffreau, V., Vincent, D., Zagnoli, F.

Publikováno v: Scientific Reports
Scientific Reports, Nature Publishing Group, 2016, 6, pp.36182. ⟨10.1038/srep36182⟩
Scientific Reports, 2016, 6, pp.36182. ⟨10.1038/srep36182⟩
Scientific Reports, Nature Publishing Group, 2016, 6, pp.36182. 〈10.1038/srep36182〉

Immunogenicity of recombinant human acid-alpha glucosidase (rhGAA) in enzyme replacement therapy (ERT) is a safety and efficacy concern in the management of late-onset Pompe disease (LOPD). However, long-term effects of ERT on humoral and cellular re

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a16807d6b8fcc2537a5ebae8baf840c3
https://hal.sorbonne-universite.fr/hal-01404918

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Innate and Adaptive Immune Response in Fabry Disease.

Autor: Mauhin, Wladimir, Lidove, Olivier, Masat, Elisa, Mingozzi, Federico, Mariampillai, Kuberaka, Ziza, Jean-Marc, Benveniste, Olivier

Publikováno v: JIMD Reports, Volume 22; 2015, p1-10, 10p